Global HIV Diagnostics Market Research Report 2023

Report ID: 1974660 | Published Date: Sep 2024 | No. of Page: 110 | Base Year: 2023 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global HIV Diagnostics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Consumables
        1.2.3 Assay, Kits and Reagents
        1.2.4 Other Consumables
        1.2.5 Instruments
        1.2.6 Software and Services
    1.3 Market by Application
        1.3.1 Global HIV Diagnostics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Antibody Tests
        1.3.3 Viral Load Tests
        1.3.4 CD4 Tests
        1.3.5 Tests for Early Infant Diagnosis
        1.3.6 Tests for Viral Identification
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global HIV Diagnostics Market Perspective (2017-2028)
    2.2 HIV Diagnostics Growth Trends by Region
        2.2.1 HIV Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 HIV Diagnostics Historic Market Size by Region (2017-2022)
        2.2.3 HIV Diagnostics Forecasted Market Size by Region (2023-2028)
    2.3 HIV Diagnostics Market Dynamics
        2.3.1 HIV Diagnostics Industry Trends
        2.3.2 HIV Diagnostics Market Drivers
        2.3.3 HIV Diagnostics Market Challenges
        2.3.4 HIV Diagnostics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top HIV Diagnostics Players by Revenue
        3.1.1 Global Top HIV Diagnostics Players by Revenue (2017-2022)
        3.1.2 Global HIV Diagnostics Revenue Market Share by Players (2017-2022)
    3.2 Global HIV Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by HIV Diagnostics Revenue
    3.4 Global HIV Diagnostics Market Concentration Ratio
        3.4.1 Global HIV Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by HIV Diagnostics Revenue in 2021
    3.5 HIV Diagnostics Key Players Head office and Area Served
    3.6 Key Players HIV Diagnostics Product Solution and Service
    3.7 Date of Enter into HIV Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 HIV Diagnostics Breakdown Data by Type
    4.1 Global HIV Diagnostics Historic Market Size by Type (2017-2022)
    4.2 Global HIV Diagnostics Forecasted Market Size by Type (2023-2028)
5 HIV Diagnostics Breakdown Data by Application
    5.1 Global HIV Diagnostics Historic Market Size by Application (2017-2022)
    5.2 Global HIV Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America HIV Diagnostics Market Size (2017-2028)
    6.2 North America HIV Diagnostics Market Size by Country (2017-2022)
    6.3 North America HIV Diagnostics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe HIV Diagnostics Market Size (2017-2028)
    7.2 Europe HIV Diagnostics Market Size by Country (2017-2022)
    7.3 Europe HIV Diagnostics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific HIV Diagnostics Market Size (2017-2028)
    8.2 Asia-Pacific HIV Diagnostics Market Size by Country (2017-2022)
    8.3 Asia-Pacific HIV Diagnostics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America HIV Diagnostics Market Size (2017-2028)
    9.2 Latin America HIV Diagnostics Market Size by Country (2017-2022)
    9.3 Latin America HIV Diagnostics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa HIV Diagnostics Market Size (2017-2028)
    10.2 Middle East & Africa HIV Diagnostics Market Size by Country (2017-2022)
    10.3 Middle East & Africa HIV Diagnostics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Detail
        11.1.2 Abbott Business Overview
        11.1.3 Abbott HIV Diagnostics Introduction
        11.1.4 Abbott Revenue in HIV Diagnostics Business (2017-2022)
        11.1.5 Abbott Recent Development
    11.2 Abbott Healthcare
        11.2.1 Abbott Healthcare Company Detail
        11.2.2 Abbott Healthcare Business Overview
        11.2.3 Abbott Healthcare HIV Diagnostics Introduction
        11.2.4 Abbott Healthcare Revenue in HIV Diagnostics Business (2017-2022)
        11.2.5 Abbott Healthcare Recent Development
    11.3 Abbvie Inc.
        11.3.1 Abbvie Inc. Company Detail
        11.3.2 Abbvie Inc. Business Overview
        11.3.3 Abbvie Inc. HIV Diagnostics Introduction
        11.3.4 Abbvie Inc. Revenue in HIV Diagnostics Business (2017-2022)
        11.3.5 Abbvie Inc. Recent Development
    11.4 Brsitol-Myers Squibb
        11.4.1 Brsitol-Myers Squibb Company Detail
        11.4.2 Brsitol-Myers Squibb Business Overview
        11.4.3 Brsitol-Myers Squibb HIV Diagnostics Introduction
        11.4.4 Brsitol-Myers Squibb Revenue in HIV Diagnostics Business (2017-2022)
        11.4.5 Brsitol-Myers Squibb Recent Development
    11.5 Janssen Therapeutics
        11.5.1 Janssen Therapeutics Company Detail
        11.5.2 Janssen Therapeutics Business Overview
        11.5.3 Janssen Therapeutics HIV Diagnostics Introduction
        11.5.4 Janssen Therapeutics Revenue in HIV Diagnostics Business (2017-2022)
        11.5.5 Janssen Therapeutics Recent Development
    11.6 Gilead Sciences
        11.6.1 Gilead Sciences Company Detail
        11.6.2 Gilead Sciences Business Overview
        11.6.3 Gilead Sciences HIV Diagnostics Introduction
        11.6.4 Gilead Sciences Revenue in HIV Diagnostics Business (2017-2022)
        11.6.5 Gilead Sciences Recent Development
    11.7 Merck & Co. Inc
        11.7.1 Merck & Co. Inc Company Detail
        11.7.2 Merck & Co. Inc Business Overview
        11.7.3 Merck & Co. Inc HIV Diagnostics Introduction
        11.7.4 Merck & Co. Inc Revenue in HIV Diagnostics Business (2017-2022)
        11.7.5 Merck & Co. Inc Recent Development
    11.8 VIIV Healthcare
        11.8.1 VIIV Healthcare Company Detail
        11.8.2 VIIV Healthcare Business Overview
        11.8.3 VIIV Healthcare HIV Diagnostics Introduction
        11.8.4 VIIV Healthcare Revenue in HIV Diagnostics Business (2017-2022)
        11.8.5 VIIV Healthcare Recent Development
    11.9 BD Biosciences
        11.9.1 BD Biosciences Company Detail
        11.9.2 BD Biosciences Business Overview
        11.9.3 BD Biosciences HIV Diagnostics Introduction
        11.9.4 BD Biosciences Revenue in HIV Diagnostics Business (2017-2022)
        11.9.5 BD Biosciences Recent Development
    11.10 Beckman Coulter
        11.10.1 Beckman Coulter Company Detail
        11.10.2 Beckman Coulter Business Overview
        11.10.3 Beckman Coulter HIV Diagnostics Introduction
        11.10.4 Beckman Coulter Revenue in HIV Diagnostics Business (2017-2022)
        11.10.5 Beckman Coulter Recent Development
    11.11 Partec
        11.11.1 Partec Company Detail
        11.11.2 Partec Business Overview
        11.11.3 Partec HIV Diagnostics Introduction
        11.11.4 Partec Revenue in HIV Diagnostics Business (2017-2022)
        11.11.5 Partec Recent Development
    11.12 Sysmex
        11.12.1 Sysmex Company Detail
        11.12.2 Sysmex Business Overview
        11.12.3 Sysmex HIV Diagnostics Introduction
        11.12.4 Sysmex Revenue in HIV Diagnostics Business (2017-2022)
        11.12.5 Sysmex Recent Development
    11.13 Apogee Flow Systems
        11.13.1 Apogee Flow Systems Company Detail
        11.13.2 Apogee Flow Systems Business Overview
        11.13.3 Apogee Flow Systems HIV Diagnostics Introduction
        11.13.4 Apogee Flow Systems Revenue in HIV Diagnostics Business (2017-2022)
        11.13.5 Apogee Flow Systems Recent Development
    11.14 PointCare Technologies Inc.
        11.14.1 PointCare Technologies Inc. Company Detail
        11.14.2 PointCare Technologies Inc. Business Overview
        11.14.3 PointCare Technologies Inc. HIV Diagnostics Introduction
        11.14.4 PointCare Technologies Inc. Revenue in HIV Diagnostics Business (2017-2022)
        11.14.5 PointCare Technologies Inc. Recent Development
    11.15 Zyomyx Inc.
        11.15.1 Zyomyx Inc. Company Detail
        11.15.2 Zyomyx Inc. Business Overview
        11.15.3 Zyomyx Inc. HIV Diagnostics Introduction
        11.15.4 Zyomyx Inc. Revenue in HIV Diagnostics Business (2017-2022)
        11.15.5 Zyomyx Inc. Recent Development
    11.16 Mylan inc.
        11.16.1 Mylan inc. Company Detail
        11.16.2 Mylan inc. Business Overview
        11.16.3 Mylan inc. HIV Diagnostics Introduction
        11.16.4 Mylan inc. Revenue in HIV Diagnostics Business (2017-2022)
        11.16.5 Mylan inc. Recent Development
    11.17 Roche Diagnostics
        11.17.1 Roche Diagnostics Company Detail
        11.17.2 Roche Diagnostics Business Overview
        11.17.3 Roche Diagnostics HIV Diagnostics Introduction
        11.17.4 Roche Diagnostics Revenue in HIV Diagnostics Business (2017-2022)
        11.17.5 Roche Diagnostics Recent Development
    11.18 Siemens Healthcare
        11.18.1 Siemens Healthcare Company Detail
        11.18.2 Siemens Healthcare Business Overview
        11.18.3 Siemens Healthcare HIV Diagnostics Introduction
        11.18.4 Siemens Healthcare Revenue in HIV Diagnostics Business (2017-2022)
        11.18.5 Siemens Healthcare Recent Development
    11.19 Qiagen
        11.19.1 Qiagen Company Detail
        11.19.2 Qiagen Business Overview
        11.19.3 Qiagen HIV Diagnostics Introduction
        11.19.4 Qiagen Revenue in HIV Diagnostics Business (2017-2022)
        11.19.5 Qiagen Recent Development
    11.20 BioMerieux
        11.20.1 BioMerieux Company Detail
        11.20.2 BioMerieux Business Overview
        11.20.3 BioMerieux HIV Diagnostics Introduction
        11.20.4 BioMerieux Revenue in HIV Diagnostics Business (2017-2022)
        11.20.5 BioMerieux Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global HIV Diagnostics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Consumables
    Table 3. Key Players of Assay, Kits and Reagents
    Table 4. Key Players of Other Consumables
    Table 5. Key Players of Instruments
    Table 6. Key Players of Software and Services
    Table 7. Global HIV Diagnostics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global HIV Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global HIV Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global HIV Diagnostics Market Share by Region (2017-2022)
    Table 11. Global HIV Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global HIV Diagnostics Market Share by Region (2023-2028)
    Table 13. HIV Diagnostics Market Trends
    Table 14. HIV Diagnostics Market Drivers
    Table 15. HIV Diagnostics Market Challenges
    Table 16. HIV Diagnostics Market Restraints
    Table 17. Global HIV Diagnostics Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global HIV Diagnostics Market Share by Players (2017-2022)
    Table 19. Global Top HIV Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Diagnostics as of 2021)
    Table 20. Ranking of Global Top HIV Diagnostics Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by HIV Diagnostics Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players HIV Diagnostics Product Solution and Service
    Table 24. Date of Enter into HIV Diagnostics Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global HIV Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global HIV Diagnostics Revenue Market Share by Type (2017-2022)
    Table 28. Global HIV Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global HIV Diagnostics Revenue Market Share by Type (2023-2028)
    Table 30. Global HIV Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global HIV Diagnostics Revenue Market Share by Application (2017-2022)
    Table 32. Global HIV Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global HIV Diagnostics Revenue Market Share by Application (2023-2028)
    Table 34. North America HIV Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America HIV Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe HIV Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe HIV Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific HIV Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific HIV Diagnostics Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America HIV Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America HIV Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa HIV Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa HIV Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Abbott Company Detail
    Table 45. Abbott Business Overview
    Table 46. Abbott HIV Diagnostics Product
    Table 47. Abbott Revenue in HIV Diagnostics Business (2017-2022) & (US$ Million)
    Table 48. Abbott Recent Development
    Table 49. Abbott Healthcare Company Detail
    Table 50. Abbott Healthcare Business Overview
    Table 51. Abbott Healthcare HIV Diagnostics Product
    Table 52. Abbott Healthcare Revenue in HIV Diagnostics Business (2017-2022) & (US$ Million)
    Table 53. Abbott Healthcare Recent Development
    Table 54. Abbvie Inc. Company Detail
    Table 55. Abbvie Inc. Business Overview
    Table 56. Abbvie Inc. HIV Diagnostics Product
    Table 57. Abbvie Inc. Revenue in HIV Diagnostics Business (2017-2022) & (US$ Million)
    Table 58. Abbvie Inc. Recent Development
    Table 59. Brsitol-Myers Squibb Company Detail
    Table 60. Brsitol-Myers Squibb Business Overview
    Table 61. Brsitol-Myers Squibb HIV Diagnostics Product
    Table 62. Brsitol-Myers Squibb Revenue in HIV Diagnostics Business (2017-2022) & (US$ Million)
    Table 63. Brsitol-Myers Squibb Recent Development
    Table 64. Janssen Therapeutics Company Detail
    Table 65. Janssen Therapeutics Business Overview
    Table 66. Janssen Therapeutics HIV Diagnostics Product
    Table 67. Janssen Therapeutics Revenue in HIV Diagnostics Business (2017-2022) & (US$ Million)
    Table 68. Janssen Therapeutics Recent Development
    Table 69. Gilead Sciences Company Detail
    Table 70. Gilead Sciences Business Overview
    Table 71. Gilead Sciences HIV Diagnostics Product
    Table 72. Gilead Sciences Revenue in HIV Diagnostics Business (2017-2022) & (US$ Million)
    Table 73. Gilead Sciences Recent Development
    Table 74. Merck & Co. Inc Company Detail
    Table 75. Merck & Co. Inc Business Overview
    Table 76. Merck & Co. Inc HIV Diagnostics Product
    Table 77. Merck & Co. Inc Revenue in HIV Diagnostics Business (2017-2022) & (US$ Million)
    Table 78. Merck & Co. Inc Recent Development
    Table 79. VIIV Healthcare Company Detail
    Table 80. VIIV Healthcare Business Overview
    Table 81. VIIV Healthcare HIV Diagnostics Product
    Table 82. VIIV Healthcare Revenue in HIV Diagnostics Business (2017-2022) & (US$ Million)
    Table 83. VIIV Healthcare Recent Development
    Table 84. BD Biosciences Company Detail
    Table 85. BD Biosciences Business Overview
    Table 86. BD Biosciences HIV Diagnostics Product
    Table 87. BD Biosciences Revenue in HIV Diagnostics Business (2017-2022) & (US$ Million)
    Table 88. BD Biosciences Recent Development
    Table 89. Beckman Coulter Company Detail
    Table 90. Beckman Coulter Business Overview
    Table 91. Beckman Coulter HIV Diagnostics Product
    Table 92. Beckman Coulter Revenue in HIV Diagnostics Business (2017-2022) & (US$ Million)
    Table 93. Beckman Coulter Recent Development
    Table 94. Partec Company Detail
    Table 95. Partec Business Overview
    Table 96. Partec HIV DiagnosticsProduct
    Table 97. Partec Revenue in HIV Diagnostics Business (2017-2022) & (US$ Million)
    Table 98. Partec Recent Development
    Table 99. Sysmex Company Detail
    Table 100. Sysmex Business Overview
    Table 101. Sysmex HIV DiagnosticsProduct
    Table 102. Sysmex Revenue in HIV Diagnostics Business (2017-2022) & (US$ Million)
    Table 103. Sysmex Recent Development
    Table 104. Apogee Flow Systems Company Detail
    Table 105. Apogee Flow Systems Business Overview
    Table 106. Apogee Flow Systems HIV DiagnosticsProduct
    Table 107. Apogee Flow Systems Revenue in HIV Diagnostics Business (2017-2022) & (US$ Million)
    Table 108. Apogee Flow Systems Recent Development
    Table 109. PointCare Technologies Inc. Company Detail
    Table 110. PointCare Technologies Inc. Business Overview
    Table 111. PointCare Technologies Inc. HIV DiagnosticsProduct
    Table 112. PointCare Technologies Inc. Revenue in HIV Diagnostics Business (2017-2022) & (US$ Million)
    Table 113. PointCare Technologies Inc. Recent Development
    Table 114. Zyomyx Inc. Company Detail
    Table 115. Zyomyx Inc. Business Overview
    Table 116. Zyomyx Inc. HIV DiagnosticsProduct
    Table 117. Zyomyx Inc. Revenue in HIV Diagnostics Business (2017-2022) & (US$ Million)
    Table 118. Zyomyx Inc. Recent Development
    Table 119. Mylan inc. Company Detail
    Table 120. Mylan inc. Business Overview
    Table 121. Mylan inc. HIV DiagnosticsProduct
    Table 122. Mylan inc. Revenue in HIV Diagnostics Business (2017-2022) & (US$ Million)
    Table 123. Mylan inc. Recent Development
    Table 124. Roche Diagnostics Company Detail
    Table 125. Roche Diagnostics Business Overview
    Table 126. Roche Diagnostics HIV DiagnosticsProduct
    Table 127. Roche Diagnostics Revenue in HIV Diagnostics Business (2017-2022) & (US$ Million)
    Table 128. Roche Diagnostics Recent Development
    Table 129. Siemens Healthcare Company Detail
    Table 130. Siemens Healthcare Business Overview
    Table 131. Siemens Healthcare HIV DiagnosticsProduct
    Table 132. Siemens Healthcare Revenue in HIV Diagnostics Business (2017-2022) & (US$ Million)
    Table 133. Siemens Healthcare Recent Development
    Table 134. Qiagen Company Detail
    Table 135. Qiagen Business Overview
    Table 136. Qiagen HIV DiagnosticsProduct
    Table 137. Qiagen Revenue in HIV Diagnostics Business (2017-2022) & (US$ Million)
    Table 138. Qiagen Recent Development
    Table 139. BioMerieux Company Detail
    Table 140. BioMerieux Business Overview
    Table 141. BioMerieux HIV DiagnosticsProduct
    Table 142. BioMerieux Revenue in HIV Diagnostics Business (2017-2022) & (US$ Million)
    Table 143. BioMerieux Recent Development
    Table 144. Research Programs/Design for This Report
    Table 145. Key Data Information from Secondary Sources
    Table 146. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global HIV Diagnostics Market Share by Type: 2021 VS 2028
    Figure 2. Consumables Features
    Figure 3. Assay, Kits and Reagents Features
    Figure 4. Other Consumables Features
    Figure 5. Instruments Features
    Figure 6. Software and Services Features
    Figure 7. Global HIV Diagnostics Market Share by Application in 2021 & 2028
    Figure 8. Antibody Tests Case Studies
    Figure 9. Viral Load Tests Case Studies
    Figure 10. CD4 Tests Case Studies
    Figure 11. Tests for Early Infant Diagnosis Case Studies
    Figure 12. Tests for Viral Identification Case Studies
    Figure 13. HIV Diagnostics Report Years Considered
    Figure 14. Global HIV Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global HIV Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global HIV Diagnostics Market Share by Region: 2021 VS 2028
    Figure 17. Global HIV Diagnostics Market Share by Players in 2021
    Figure 18. Global Top HIV Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Diagnostics as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by HIV Diagnostics Revenue in 2021
    Figure 20. North America HIV Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. North America HIV Diagnostics Market Share by Country (2017-2028)
    Figure 22. United States HIV Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada HIV Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe HIV Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe HIV Diagnostics Market Share by Country (2017-2028)
    Figure 26. Germany HIV Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France HIV Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. HIV Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy HIV Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia HIV Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries HIV Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific HIV Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific HIV Diagnostics Market Share by Region (2017-2028)
    Figure 34. China HIV Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Japan HIV Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. South Korea HIV Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Southeast Asia HIV Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. India HIV Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Australia HIV Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America HIV Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America HIV Diagnostics Market Share by Country (2017-2028)
    Figure 42. Mexico HIV Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Brazil HIV Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa HIV Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Middle East & Africa HIV Diagnostics Market Share by Country (2017-2028)
    Figure 46. Turkey HIV Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Saudi Arabia HIV Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Abbott Revenue Growth Rate in HIV Diagnostics Business (2017-2022)
    Figure 49. Abbott Healthcare Revenue Growth Rate in HIV Diagnostics Business (2017-2022)
    Figure 50. Abbvie Inc. Revenue Growth Rate in HIV Diagnostics Business (2017-2022)
    Figure 51. Brsitol-Myers Squibb Revenue Growth Rate in HIV Diagnostics Business (2017-2022)
    Figure 52. Janssen Therapeutics Revenue Growth Rate in HIV Diagnostics Business (2017-2022)
    Figure 53. Gilead Sciences Revenue Growth Rate in HIV Diagnostics Business (2017-2022)
    Figure 54. Merck & Co. Inc Revenue Growth Rate in HIV Diagnostics Business (2017-2022)
    Figure 55. VIIV Healthcare Revenue Growth Rate in HIV Diagnostics Business (2017-2022)
    Figure 56. BD Biosciences Revenue Growth Rate in HIV Diagnostics Business (2017-2022)
    Figure 57. Beckman Coulter Revenue Growth Rate in HIV Diagnostics Business (2017-2022)
    Figure 58. Partec Revenue Growth Rate in HIV Diagnostics Business (2017-2022)
    Figure 59. Sysmex Revenue Growth Rate in HIV Diagnostics Business (2017-2022)
    Figure 60. Apogee Flow Systems Revenue Growth Rate in HIV Diagnostics Business (2017-2022)
    Figure 61. PointCare Technologies Inc. Revenue Growth Rate in HIV Diagnostics Business (2017-2022)
    Figure 62. Zyomyx Inc. Revenue Growth Rate in HIV Diagnostics Business (2017-2022)
    Figure 63. Mylan inc. Revenue Growth Rate in HIV Diagnostics Business (2017-2022)
    Figure 64. Roche Diagnostics Revenue Growth Rate in HIV Diagnostics Business (2017-2022)
    Figure 65. Siemens Healthcare Revenue Growth Rate in HIV Diagnostics Business (2017-2022)
    Figure 66. Qiagen Revenue Growth Rate in HIV Diagnostics Business (2017-2022)
    Figure 67. BioMerieux Revenue Growth Rate in HIV Diagnostics Business (2017-2022)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott
Abbott Healthcare
Abbvie Inc.
Brsitol-Myers Squibb
Janssen Therapeutics
Gilead Sciences
Merck & Co. Inc
VIIV Healthcare
BD Biosciences
Beckman Coulter
Partec
Sysmex
Apogee Flow Systems
PointCare Technologies Inc.
Zyomyx Inc.
Mylan inc.
Roche Diagnostics
Siemens Healthcare
Qiagen
BioMerieux
Frequently Asked Questions
HIV Diagnostics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
HIV Diagnostics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
HIV Diagnostics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports